943 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
4 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
5 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
6 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
7 Not yet recruiting Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Thoracic Surgery
Interventions: Procedure: Video-assisted thoracoscopic surgery;   Procedure: Robotic thoracic surgery
8 Recruiting Study of Tesevatinib in Subjects With Non-Small Cell Lung Cancer, EGFR Activating Mutation, Prior Treatment With a Tyrosine Kinase Inhibitor, and Brain Metastases or Leptomeningeal Metastases
Conditions: Non-Small Cell Lung Cancer;   Leptomeningeal Metastases;   Brain Metastases
Intervention: Drug: Tesevatinib
9 Not yet recruiting Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Nivolumab;   Drug: Docetaxel
10 Not yet recruiting A Dose Escalation Study of JNJ-61186372 in Participants With Advanced Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: Part 1 (Dose Escalation): JNJ-61186372;   Drug: Part 2 (Dose Expansion): JNJ-61186372
11 Recruiting Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy
Condition: Non-small Cell Lung Cancer Starting Anti-PD1/PDL1 Therapy
Intervention: Radiation: [18F]fluoroglucose(FDG)
12 Recruiting TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)
Condition: Carcinoma, Small Cell
Intervention: Drug: ARQ197
13 Not yet recruiting Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors
Conditions: Non-small Cell Lung Cancer;   Advanced Solid Tumor
Interventions: Drug: Stereotactic body radiotherapy;   Drug: Pembrolizumab
14 Recruiting A Prospective Multi-center Phase III Randomized Controlled Trial
Condition: Carcinoma,Non-Small-Cell Lung
Interventions: Drug: cisplatin and pemetrexed;   Drug: nadaplatin+pemetrexed
15 Not yet recruiting Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed With Surgery
Condition: Stage IIIA Non-Small Cell Lung Cancer
Interventions: Drug: Cisplatin;   Procedure: Computed Tomography;   Drug: Docetaxel;   Radiation: Fludeoxyglucose F-18;   Drug: Gemcitabine Hydrochloride;   Drug: Pemetrexed Disodium;   Procedure: Positron Emission Tomography
16 Recruiting Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer
Conditions: Small Cell Lung Cancer;   Metastatic Carcinoma
Interventions: Drug: temozolomide;   Radiation: prophylaxis cranial radiotherapy
17 Recruiting Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib
Condition: Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer
Interventions: Drug: Alectinib;   Drug: Docetaxel;   Drug: Pemetrexed
18 Not yet recruiting Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
Condition: Stage I Non-Small Cell Lung Cancer
Interventions: Drug: Atezolizumab;   Radiation: Stereotactic Body Radiation Therapy
19 Recruiting 18F-FSPG PET/CT for Cancer Patients on Therapy
Conditions: B-Cell Neoplasm;   Estrogen Receptor Negative;   HER2/Neu Negative;   Metastatic Renal Cell Cancer;   Progesterone Receptor Negative;   Stage III Mesothelioma;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Mesothelioma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Renal Cell Cancer;   Triple-Negative Breast Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Fluorine F 18 L-glutamate Derivative BAY94-9392;   Procedure: Positron Emission Tomography;   Procedure: Magnetic Resonance Imaging
20 Not yet recruiting Afatinib in NSCLC With HER2 Mutation
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: afatinib;   Drug: paclitaxel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years